Literature DB >> 18823803

Severe iron overload with a novel aminolevulinate synthase mutation and hepatitis C infection. A case report.

Pauline Lee1, Lawrence Rice, John J McCarthy, Ernest Beutler.   

Abstract

A 55 year old man with a history of chronic hepatitis C infection was found to have severe hemochromatosis: hepatic cirrhosis, cardiomyopathy, arrhythmia, hypogonadism, diabetes and bronzed skin color. After 50 phlebotomies, he underwent a combined heart and liver transplant. Genetic analyses identified a novel mutation in the iron responsive element of the ALAS2 gene. No mutations were found in other genes associated with adult or juvenile hemochromatosis including HFE, transferrin receptor-2 (TFR2), ferroportin (SLC40A1), hepcidin (HAMP) and hemojuvelin (HJV). We suggest that the ALAS2 mutation together with chronic hepatitis C infection may have caused the severe iron overload phenotype.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18823803      PMCID: PMC2696479          DOI: 10.1016/j.bcmd.2008.08.001

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  18 in total

1.  A mutation, in the iron-responsive element of H ferritin mRNA, causing autosomal dominant iron overload.

Authors:  J Kato; K Fujikawa; M Kanda; N Fukuda; K Sasaki; T Takayama; M Kobune; K Takada; R Takimoto; H Hamada; T Ikeda; Y Niitsu
Journal:  Am J Hum Genet       Date:  2001-05-24       Impact factor: 11.025

2.  Hereditary hyperferritinemia-cataract syndrome: relationship between phenotypes and specific mutations in the iron-responsive element of ferritin light-chain mRNA.

Authors:  M Cazzola; G Bergamaschi; L Tonon; E Arbustini; M Grasso; E Vercesi; G Barosi; P E Bianchi; G Cairo; P Arosio
Journal:  Blood       Date:  1997-07-15       Impact factor: 22.113

3.  Absent phenotypic expression of X-linked sideroblastic anemia in one of 2 brothers with a novel ALAS2 mutation.

Authors:  Mario Cazzola; Alison May; Gaetano Bergamaschi; Paola Cerani; Sara Ferrillo; David F Bishop
Journal:  Blood       Date:  2002-08-08       Impact factor: 22.113

4.  A study of genes that may modulate the expression of hereditary hemochromatosis: transferrin receptor-1, ferroportin, ceruloplasmin, ferritin light and heavy chains, iron regulatory proteins (IRP)-1 and -2, and hepcidin.

Authors:  P L Lee; T Gelbart; C West; C Halloran; V Felitti; E Beutler
Journal:  Blood Cells Mol Dis       Date:  2001 Sep-Oct       Impact factor: 3.039

5.  A promoter mutation in the erythroid-specific 5-aminolevulinate synthase (ALAS2) gene causes X-linked sideroblastic anemia.

Authors:  Soumeya Bekri; Alison May; Philip D Cotter; Ala I Al-Sabah; Xiaojun Guo; Gillian S Masters; David F Bishop
Journal:  Blood       Date:  2003-03-27       Impact factor: 22.113

6.  Disruption of ferroportin 1 regulation causes dynamic alterations in iron homeostasis and erythropoiesis in polycythaemia mice.

Authors:  Henry Mok; Jaroslav Jelinek; Sonia Pai; Bruce M Cattanach; Josef T Prchal; Hagop Youssoufian; Armin Schumacher
Journal:  Development       Date:  2004-04       Impact factor: 6.868

7.  Genetic abnormalities and juvenile hemochromatosis: mutations of the HJV gene encoding hemojuvelin.

Authors:  Pauline L Lee; Ernest Beutler; Sreenivas V Rao; James C Barton
Journal:  Blood       Date:  2004-02-24       Impact factor: 22.113

8.  Human erythroid 5-aminolevulinate synthase: promoter analysis and identification of an iron-responsive element in the mRNA.

Authors:  T C Cox; M J Bawden; A Martin; B K May
Journal:  EMBO J       Date:  1991-07       Impact factor: 11.598

9.  Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis.

Authors:  Antonella Roetto; George Papanikolaou; Marianna Politou; Federica Alberti; Domenico Girelli; John Christakis; Dimitris Loukopoulos; Clara Camaschella
Journal:  Nat Genet       Date:  2002-12-09       Impact factor: 38.330

10.  Spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis.

Authors:  Carmela Lanzara; Antonella Roetto; Filomena Daraio; Silvain Rivard; Romina Ficarella; Hervey Simard; Timothy M Cox; Mario Cazzola; Alberto Piperno; Anne-Paule Gimenez-Roqueplo; Paola Grammatico; Stefano Volinia; Paolo Gasparini; Clara Camaschella
Journal:  Blood       Date:  2004-02-24       Impact factor: 22.113

View more
  4 in total

1.  Delta-aminolevulinate synthase 2 polymorphism is associated with maximal oxygen uptake after Living-high exercise-high training-low in a male Chinese population.

Authors:  Yali Xu; Yang Hu; Zhijun Ren; Longyan Yi
Journal:  Int J Clin Exp Med       Date:  2015-11-15

Review 2.  Role of heme in cardiovascular physiology and disease.

Authors:  Konrad Teodor Sawicki; Hsiang-Chun Chang; Hossein Ardehali
Journal:  J Am Heart Assoc       Date:  2015-01-05       Impact factor: 5.501

3.  Sideroblastic anemia: functional study of two novel missense mutations in ALAS2.

Authors:  Manuel Méndez; María-Isabel Moreno-Carralero; Marta Morado-Arias; María-Cristina Fernández-Jiménez; Silvia de la Iglesia Iñigo; María-José Morán-Jiménez
Journal:  Mol Genet Genomic Med       Date:  2016-01-13       Impact factor: 2.183

4.  Increased Heme Levels in the Heart Lead to Exacerbated Ischemic Injury.

Authors:  Konrad Teodor Sawicki; Meng Shang; Rongxue Wu; Hsiang-Chun Chang; Arineh Khechaduri; Tatsuya Sato; Christine Kamide; Ting Liu; Sathyamangla V Naga Prasad; Hossein Ardehali
Journal:  J Am Heart Assoc       Date:  2015-07-31       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.